
Tactile Systems (TCMD) Stock Forecast & Price Target
Tactile Systems (TCMD) Analyst Ratings
Bulls say
Tactile Systems Tech is a leader in the lymphedema market with a strong revenue growth trajectory and a recent acquisition to enhance their product offerings. The company has made strategic changes to their sales structure and technology platforms, positioning them for continued success. Challenges with prior authorization may impact their growth in the short term, but their long-term outlook remains positive.
Bears say
Tactile Systems Tech is expected to experience sluggish growth in 2026, driven primarily by the projected decrease in sales for its Airway Clearance segment. While there are hopes that LymphaTech may provide modest grant-related revenue in FY26, its acquisition adds to TCMD's expenses, which may weigh on profitability moving forward. Additionally, risks such as competition within Airway Clearance and potential disruptions from Medicare prior authorization requirements could hinder the company's performance in the future. Overall, the negative outlook is based on the company's current challenges and potential risks that may impact its growth and profitability in the coming years.
This aggregate rating is based on analysts' research of Tactile Systems and is not a guaranteed prediction by Public.com or investment advice.
Tactile Systems (TCMD) Analyst Forecast & Price Prediction
Start investing in Tactile Systems (TCMD)
Order type
Buy in
Order amount
Est. shares
0 shares